Real-time enrollment status for this cardiovascular disease and lipoprotein(a) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:26 PM UTC
| NCT Number | NCT07517263 |
| Recruiting Status | Recruiting |
| Condition | Cardiovascular Disease and Lipoprotein(a) |
| Phase | PHASE3 |
| Target Enrollment | 5,700 participants |
| Active Locations | 124 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | September 4, 2026 (Sep 4, 2026) |
As of October 12, 2026: Clinical trial NCT07517263 is currently recruiting participants. This phase3 study for cardiovascular disease and lipoprotein(a) is actively seeking new participants at 124 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07517263 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 124 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07517263 was last updated Sep 4, 2026 (September 4, 2026). HelloStudys verifies this status automatically.